维普中文期刊产品整合服务
7篇 您的检索式:作者名="Steiniger SC"
    题名 作者 年代 出处 被引量
1Chemotherapy of glioblastoma in rats using doxorubicin - loaded nanoparticles显示文摘Glioblastomas belong to the most aggressive human cancers with short survival times.Due to the blood-brainbarrier,they are mostly inaccessible to traditional chemotherapy.We have recently shown that doxorubicin boundto polysorbate-coated nanoparticles crossed the intact blood-brain barrier,thus reaching therapeutic concentra-tions in the brain.Here,we investigated the therapeutic potential of this formulation of doxorubicin in vivo using ananimal model created by implantation of 101/8 glioblastoma tumor in rat brains.Groups of 5-8 glioblastoma-Steiniger SC Kreuter J Khalansky AS Skidan IN Bobruskin I Smirnova ZS Severin SE Uhl R Kock M Geiger KD Gelperina SE 2004中国神经肿瘤杂志2004,2,1:13
2Targeting heat shock proteins on cancer ceils : selection, characterization, and cell - penetrating properties of a peptidic GRP78 ligand 显示文摘Kim Y Lillo AM Steiniger SC 2006Biochemistry2006,45,31:1
3Cationic lipid-protamine-DNA(LPD) complexes for delivery of antisense c-myc oligonucleotides显示文摘Junghans M Loitsch SM Steiniger SC 2005Eur J Pharm Biopharm2005,60,2:1
4Quantitative mass spectrometry identifies drug targets in cancer stem cell-contai- ning side population显示文摘Steiniger SC Coppinger JA Kruger JA 2008Stem Cells2008,26,12:1
5Targeting heat s hock proteins on cancer cells : selection, characterization, and cell - penetrating proper- ties of a peptidic GRP'/8 ligand 显示文摘Kim Y Lillo AM Steiniger SC 2006Biochemistry2006,45,:1
6A cell-penetrating peptidic GRP78 ligand for tumor cell-specific prodrug therapy 显示文摘Yoneda Y Steiniger SC Capkova K Mee JM Liu Y Kaufmann GF 2008Bioorg Med Chem Lett2008,18,5:1
7Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen显示文摘Steiniger SC Altobell LJ Zhou B 2007Mol Immunol2007,44,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费